Aptus Endosystems, Inc.

Aptus Endosystems receives $19.5M in series B financing

Published in Lab Business Week, April 30th, 2006

Aptus Endosystems, Inc., a medical device company developing technology and products for the treatment of endovascular aneurysm repair, has raised $19.5 million in Series B financing.

This latest round was led by Prism Venture Partners and joined by Baird Venture Partners, both new investors. Existing investors U.S. Venture Partners and Pequot Ventures also participated in this round.

Aptus Endosystems will use the proceeds to support continuing development activities, initiate the U.S. clinical trial program, STAPLE-1, for its Abdominal Aortic Aneurysm (AAA) product; and build its operations infrastructure.

"We are pleased to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-04-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry